• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在黑色素瘤细胞中鉴定出一种半胱氨酸蛋白酶p39,该酶可裂解补体第三成分C3:与组织蛋白酶L原的氨基酸序列一致性。

Identification on melanoma cells of p39, a cysteine proteinase that cleaves C3, the third component of complement: amino-acid-sequence identities with procathepsin L.

作者信息

Jean D, Hermann J, Rodrigues-Lima F, Barel M, Balbo M, Frade R

机构信息

Immunochimie des Régulations Cellulaires et des Interactions Virales, INSERM U.354, Centre INSERM, Hôpital Saint-Antonie, Paris, France.

出版信息

Biochem J. 1995 Dec 15;312 ( Pt 3)(Pt 3):961-9. doi: 10.1042/bj3120961.

DOI:10.1042/bj3120961
PMID:8554545
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1136207/
Abstract

We previously identified, on normal or tumour cells, two membrane proteinases, p57 and p65, that cleave human C3, the third component of complement, thus regulating C3's biological properties. Whereas p57 was purified from human erythrocytes, p65 was identified using polyclonal anti-p57 antibodies on a human melanoma cell line resistant to complement lysis. Analysis of cell distribution of C3-cleaving proteinases established that DSm, a murine melanoma cell line, expressed a C3-cleaving proteinase distinct from p57 and p65 proteinases. Thus we purified the C3-cleaving proteinase solubilized from membranes of DSm cells. The purified proteinase, termed 'p39' on the basis of its molecular mass of 39 kDa, was identified, using specific proteinase inhibitors, as a cysteine proteinase. Anti-p39 antibodies, prepared against highly purified p39, localized the p39 C3-cleaving proteinase mainly at the cell surface and demonstrated that p39 is also secreted. Anti-p39 antibodies inhibited solubilized C3-cleaving activity. Preincubation of DSm cells with anti-p39 F(ab')2 fragments increased up to 60% complement cell susceptibility. Amino acid analysis of N-terminal and three other regions of p39 demonstrated that this C3-cleaving proteinase carries 100% identity within four regions of procathepsin L. This is the first demonstration that a melanoma cell line expresses on its surface and secretes a p39 C3-cleaving cysteine proteinase that shares sequence identities with procathepsin L. Thus the p39 cysteine proteinase represents a new member of the C3-cleaving proteinase family associated with, and/or expressed on, the cell surface.

摘要

我们之前在正常细胞或肿瘤细胞上鉴定出了两种膜蛋白酶,即p57和p65,它们可切割补体的第三成分人C3,从而调节C3的生物学特性。p57是从人红细胞中纯化得到的,而p65是在一种对补体溶解有抗性的人黑色素瘤细胞系上,利用多克隆抗p57抗体鉴定出来的。对切割C3的蛋白酶的细胞分布分析表明,小鼠黑色素瘤细胞系DSm表达一种与p57和p65蛋白酶不同的切割C3的蛋白酶。因此,我们纯化了从DSm细胞膜上溶解下来的切割C3的蛋白酶。根据其39 kDa的分子量,该纯化的蛋白酶被称为“p39”,利用特异性蛋白酶抑制剂鉴定其为半胱氨酸蛋白酶。针对高度纯化的p39制备的抗p39抗体将p39切割C3的蛋白酶主要定位在细胞表面,并证明p39也会分泌。抗p39抗体抑制了溶解状态下的C3切割活性。用抗p39 F(ab')2片段对DSm细胞进行预孵育,可使补体对细胞的敏感性提高多达60%。对p39的N端和其他三个区域进行氨基酸分析表明,这种切割C3的蛋白酶在组织蛋白酶L原的四个区域内具有100%的同一性。这是首次证明黑色素瘤细胞系在其表面表达并分泌一种与组织蛋白酶L原具有序列同一性的p39切割C3的半胱氨酸蛋白酶。因此,p39半胱氨酸蛋白酶代表了与细胞表面相关和/或在细胞表面表达的切割C3的蛋白酶家族的一个新成员。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffb1/1136207/bc2a78b633d9/biochemj00049-0302-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffb1/1136207/36760d19bab8/biochemj00049-0299-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffb1/1136207/3aaf4a6d8097/biochemj00049-0300-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffb1/1136207/10bc5d0b5120/biochemj00049-0300-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffb1/1136207/e4fe626bb0d2/biochemj00049-0301-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffb1/1136207/cb97f1c1983e/biochemj00049-0301-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffb1/1136207/a627b6986a14/biochemj00049-0301-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffb1/1136207/bc2a78b633d9/biochemj00049-0302-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffb1/1136207/36760d19bab8/biochemj00049-0299-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffb1/1136207/3aaf4a6d8097/biochemj00049-0300-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffb1/1136207/10bc5d0b5120/biochemj00049-0300-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffb1/1136207/e4fe626bb0d2/biochemj00049-0301-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffb1/1136207/cb97f1c1983e/biochemj00049-0301-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffb1/1136207/a627b6986a14/biochemj00049-0301-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffb1/1136207/bc2a78b633d9/biochemj00049-0302-a.jpg

相似文献

1
Identification on melanoma cells of p39, a cysteine proteinase that cleaves C3, the third component of complement: amino-acid-sequence identities with procathepsin L.在黑色素瘤细胞中鉴定出一种半胱氨酸蛋白酶p39,该酶可裂解补体第三成分C3:与组织蛋白酶L原的氨基酸序列一致性。
Biochem J. 1995 Dec 15;312 ( Pt 3)(Pt 3):961-9. doi: 10.1042/bj3120961.
2
A cysteine proteinase, which cleaves human C3, the third component of complement, is involved in tumorigenicity and metastasis of human melanoma.一种可切割人补体第三成分C3的半胱氨酸蛋白酶,参与人黑色素瘤的致瘤性和转移过程。
Cancer Res. 1996 Jan 15;56(2):254-8.
3
Co-expression and secretion of C3, the third component of complement and a C3-cleaving cysteine proteinase in a highly metastatic human melanoma cell line.补体第三成分C3与一种可裂解C3的半胱氨酸蛋白酶在高转移性人黑色素瘤细胞系中的共表达及分泌
Immunol Lett. 1997 Jul;58(2):107-12. doi: 10.1016/s0165-2478(97)00030-8.
4
Structure and functions of proteases which cleave human C3 and are expressed on normal or tumor human cells: some are involved in tumorigenic and metastatic properties of human melanoma cells.可切割人C3并在正常或肿瘤人细胞上表达的蛋白酶的结构与功能:其中一些与人类黑色素瘤细胞的致瘤性和转移特性有关。
Immunopharmacology. 1999 May;42(1-3):39-45. doi: 10.1016/s0162-3109(99)00028-4.
5
C3-cleaving membrane proteinase. A new complement regulatory protein of human melanoma cells.C3裂解膜蛋白酶。人黑素瘤细胞的一种新的补体调节蛋白。
J Immunol. 1990 May 15;144(10):3862-7.
6
Human erythrocyte ankyrin, a cytoskeleton component, generates the p57 membrane proteinase which cleaves C3, the third component of complement.
Biochem Biophys Res Commun. 1994 Oct 28;204(2):453-60. doi: 10.1006/bbrc.1994.2481.
7
Procathepsin-L, a proteinase that cleaves human C3 (the third component of complement), confers high tumorigenic and metastatic properties to human melanoma cells.组织蛋白酶原-L是一种可裂解人C3(补体第三成分)的蛋白酶,它赋予人黑色素瘤细胞高致瘤性和转移特性。
Cancer Res. 1998 Jul 1;58(13):2733-6.
8
Alpha 1-proteinase inhibitor is the serum regulator of the activity of p57, a C3-cleaving proteinase present in human erythrocyte membranes.
Biochim Biophys Acta. 1998 Mar 27;1402(2):131-8. doi: 10.1016/s0167-4889(97)00153-5.
9
Cloning and characterization of anti-cathepsin L single chain variable fragment whose expression inhibits procathepsin L secretion in human melanoma cells.抗组织蛋白酶L单链可变片段的克隆与鉴定,其表达可抑制人黑色素瘤细胞中组织蛋白酶L原的分泌。
Biochem J. 2002 Oct 1;367(Pt 1):219-27. doi: 10.1042/BJ20020350.
10
Cleavage of C3 by a neutral cysteine proteinase of Entamoeba histolytica.溶组织内阿米巴的一种中性半胱氨酸蛋白酶对C3的裂解作用。
J Immunol. 1989 Jul 1;143(1):189-95.

引用本文的文献

1
Lysosomal peptidases-intriguing roles in cancer progression and neurodegeneration.溶酶体肽酶——在癌症进展和神经退行性变中的有趣作用。
FEBS Open Bio. 2022 Apr;12(4):708-738. doi: 10.1002/2211-5463.13372. Epub 2022 Feb 3.
2
Complement C5b-9 and Cancer: Mechanisms of Cell Damage, Cancer Counteractions, and Approaches for Intervention.补体 C5b-9 与癌症:细胞损伤的机制、癌症的拮抗作用及干预方法。
Front Immunol. 2019 Apr 10;10:752. doi: 10.3389/fimmu.2019.00752. eCollection 2019.
3
Cathepsin L targeting in cancer treatment.癌症治疗中的组织蛋白酶L靶向作用。

本文引用的文献

1
Associated complement C3b. Towards an understanding of its intracellular modifications.相关补体C3b。旨在了解其细胞内修饰。
Mol Immunol. 1993 Jul;30(10):855-64. doi: 10.1016/0161-5890(93)90009-z.
2
Membrane cofactor protein (CD46) of complement. Processing differences related to alternatively spliced cytoplasmic domains.补体的膜辅助蛋白(CD46)。与可变剪接的胞质结构域相关的加工差异。
J Biol Chem. 1994 Apr 8;269(14):10776-9.
3
Inhibition of cathepsin L-like cysteine proteases by cytotoxic T-lymphocyte antigen-2 beta.细胞毒性T淋巴细胞抗原2β对组织蛋白酶L样半胱氨酸蛋白酶的抑制作用
Pharmacol Ther. 2015 Nov;155:105-16. doi: 10.1016/j.pharmthera.2015.08.007. Epub 2015 Aug 20.
4
Cathepsin L increased level upon Ras mutants expression: the role of p38 and p44/42 MAPK signaling pathways.组织蛋白酶 L 在 Ras 突变体表达时水平增加:p38 和 p44/42 MAPK 信号通路的作用。
Mol Cell Biochem. 2010 Oct;343(1-2):49-57. doi: 10.1007/s11010-010-0497-3. Epub 2010 Jun 4.
5
Cloning and characterization of anti-cathepsin L single chain variable fragment whose expression inhibits procathepsin L secretion in human melanoma cells.抗组织蛋白酶L单链可变片段的克隆与鉴定,其表达可抑制人黑色素瘤细胞中组织蛋白酶L原的分泌。
Biochem J. 2002 Oct 1;367(Pt 1):219-27. doi: 10.1042/BJ20020350.
6
Characterization of human cathepsin L promoter and identification of binding sites for NF-Y, Sp1 and Sp3 that are essential for its activity.人组织蛋白酶L启动子的特征分析以及对其活性至关重要的NF-Y、Sp1和Sp3结合位点的鉴定。
Biochem J. 2002 Jan 1;361(Pt 1):173-84. doi: 10.1042/0264-6021:3610173.
7
Regulation of CR3 (CD11b/CD18)-dependent natural killer (NK) cell cytotoxicity by tumour target cell MHC class I molecules.肿瘤靶细胞MHC I类分子对CR3(CD11b/CD18)依赖性自然杀伤(NK)细胞细胞毒性的调节作用。
Clin Exp Immunol. 1999 Feb;115(2):229-35. doi: 10.1046/j.1365-2249.1999.00800.x.
J Biol Chem. 1994 Oct 7;269(40):25172-7.
4
Human erythrocyte ankyrin, a cytoskeleton component, generates the p57 membrane proteinase which cleaves C3, the third component of complement.
Biochem Biophys Res Commun. 1994 Oct 28;204(2):453-60. doi: 10.1006/bbrc.1994.2481.
5
The physiological breakdown of the third component of human complement.人类补体第三成分的生理分解。
Mol Immunol. 1980 Jan;17(1):9-20. doi: 10.1016/0161-5890(80)90119-4.
6
Behavior of soluble human 125I-labeled C3b, the third component of complement, after binding to human cells.可溶性人125I标记的补体第三成分C3b与人细胞结合后的行为。
Eur J Immunol. 1982 Apr;12(4):289-94. doi: 10.1002/eji.1830120407.
7
A one-step purification of membrane proteins using a high efficiency immunomatrix.使用高效免疫基质一步纯化膜蛋白。
J Biol Chem. 1982 Sep 25;257(18):10766-9.
8
Large scale isolation of functionally active components of the human complement system.大规模分离人补体系统的功能活性成分。
J Biol Chem. 1981 Apr 25;256(8):3995-4006.
9
Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes.衰变加速因子(DAF)整合到细胞膜后对细胞表面补体激活的抑制作用。
J Exp Med. 1984 Nov 1;160(5):1558-78. doi: 10.1084/jem.160.5.1558.
10
Molecular biology and chemistry of the alternative pathway of complement.补体替代途径的分子生物学与化学
Adv Immunol. 1980;29:1-53. doi: 10.1016/s0065-2776(08)60042-5.